These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15519651)

  • 1. Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo.
    Hisaka T; Yano H; Ogasawara S; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Katafuchi Y; Kojiro M
    J Hepatol; 2004 Nov; 41(5):782-9. PubMed ID: 15519651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
    Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
    Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
    Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
    Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.
    Kusano H; Akiba J; Ogasawara S; Sanada S; Yasumoto M; Nakayama M; Ueda K; Ueda K; Kurita T; Todoroki K; Umeno Y; Nakashima O; Yano H
    PLoS One; 2013; 8(12):e83195. PubMed ID: 24349459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.
    Cao B; Chen XP; Zhu P; Ding L; Guan J; Shi ZL
    World J Gastroenterol; 2008 Nov; 14(44):6802-7. PubMed ID: 19058305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
    Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
    J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo.
    Ogasawara S; Yano H; Momosaki S; Akiba J; Nishida N; Kojiro S; Moriya F; Ishizaki H; Kuratomi K; Kojiro M
    J Interferon Cytokine Res; 2007 Jun; 27(6):507-16. PubMed ID: 17572015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of sorafenib and pegylated IFN‑α2b on human liver cancer cells in vitro and in vivo.
    Kusano H; Ogasawara S; Akiba J; Nakayama M; Ueda K; Yano H
    Int J Oncol; 2013 Jun; 42(6):1897-903. PubMed ID: 23588838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory function of interferon on hepatocarcinogenesis.
    Yano H
    Oncology; 2008; 75 Suppl 1():22-9. PubMed ID: 19092269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
    Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
    FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines
    Ogasawara S; Mihara Y; Kondo R; Kusano H; Akiba J; Yano H
    Anticancer Res; 2019 Nov; 39(11):5973-5982. PubMed ID: 31704822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus interferon enhances the anti-proliferative effect of 5-fluorouracil on human hepatoma cells via downregulation of dihydropyrimidine dehydrogenase expression.
    Dou J; Iwashita Y; Sasaki A; Kai S; Hirano S; Ohta M; Kitano S
    Liver Int; 2005 Feb; 25(1):148-52. PubMed ID: 15698412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
    Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Wang L; Tang ZY; Qin LX; Wu XF; Sun HC; Xue Q; Ye SL
    Hepatology; 2000 Jul; 32(1):43-8. PubMed ID: 10869287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interferon-alpha on recurrence and metastasis of hepatocellular carcinoma after curative resection in nude mice.
    Wang L; Tang Z; Xue Q; Sun H; Chen J; Gao D; Zhao Y; Chen J; Sun R; Liu Y; Ye S
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):154-6. PubMed ID: 11412390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
    Nagler A; Ohana M; Shibolet O; Shapira MY; Alper R; Vlodavsky I; Pines M; Ilan Y
    Eur J Cancer; 2004 Jun; 40(9):1397-403. PubMed ID: 15177499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.
    Ogasawara S; Yano H; Iemura A; Hisaka T; Kojiro M
    Hepatology; 1996 Jul; 24(1):198-205. PubMed ID: 8707262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.